Pharmaceutical Analytical Testing Outsourcing Market 2022: Driving Factors, Business Strategies and Industry Size Forecast to 2027


 

Market research future will be publishing a cooked research report on “Global Pharmaceutical Analytical Testing Outsourcing Market” that contains the information from 2015 to 2023. The pharmaceutical analytical testing outsourcing market is expected to register a CAGR of 8.6% during the forecast period of 2018 to 2023.

Market Research Future (MRFR) recognizes following companies as key players in the global pharmaceutical analytical testing outsourcing market that include Exova Group PLC (UK), Boston Analytical (New Hampshire), Charles River Laboratories International, Inc. (US), West Pharmaceutical Services, Inc. (US), Merck KGaA (Germany), WuXi AppTec (US), Source BioScience (UK), SGS SA (UK), Toxikon (US), Eurofins Scientific (Belgium), Pace Analytical Services, LLC (US), Intertek Group PLC (London), Pharmaceutical Product Development, LLC (US), and others.

Market Highlights

The Global Pharmaceutical Analytical Testing Outsourcing Market is expected toregister a CAGR of 8.6% during the forecast period with a market value of USD 4,957.3 million in 2017. Pharmaceutical analytical testing outsourcing plays an important role in drug development and manufacturing process. It helps in providing information regarding the safety and quality of raw materials and finished products. Government and other organizations are investing in R&D to develop drugs for various chronic diseases. According to the National Institute for Health Research, the Association of the British Pharmaceutical Industry (ABPI) invested around Euro 4.1 billion on research and development, for innovating new drugs for cancer, dementia, and rare genetic diseases in the UK in January 2019.

Get Sample Report: https://www.marketresearchfuture.com/sample_request/7188

Growing pharmaceutical industry, increasing demand for analytical details on drugs & process development by regulatory agencies and rising prevalence of cancer and other infectious diseases have led to the growth of the global pharmaceutical analytical testing outsourcing market in the recent years. However, the high cost of drug discovery and inconsistencies in the quality of products are likely to restrain the market growth over the forecast period.

Segment Analysis

The global pharmaceutical analytical testing outsourcing market, by product type, has been segmented into finished products, active pharmaceutical ingredients, and raw materials. The finished products segment accounted for a value of USD 2,055.4 million in 2017. The market, by services, can be segmented into bioanalytical testing, method development & validation, stability testing, and others. On the basis of end user, the global pharmaceutical analytical testing outsourcing market is segmented into pharmaceutical & biopharmaceutical companies and biotechnology industry.

 

Regional Analysis

The Americas is expected to hold the largest share of the global pharmaceutical analytical testing outsourcing market. This is owing to the increasing prevalence of chronic diseases and a growing number of contract research organizations (CROs) in the region. Europe market demonstrated a good growth in the market due to growth in the pharmaceutical sector, increasing government funding to promote research and development for the prevention of chronic diseases, and increased healthcare spending. Asia-Pacific is estimated to be the fastest growing region in the global market due to the presence of a large number of research organizations, low manufacturing & labor cost, and development of new infrastructure to support the healthcare industry. Australia held a share of 8.8% in the Asia-Pacific pharmaceutical analytical testing outsourcing market in 2017. Also, the Middle East and Africa region is expected to show the least growth owing to low per capita income and lack of adequate healthcare spending.

Key Findings of the Study

The global pharmaceutical analytical testing outsourcing market is projected to reach USD 8,095.0 million by 2023 at a CAGR of 8.6% during the review period from 2018 to 2023.

Americas accounted for the largest share of the global market due to the increasing number of CROs in the region.

The finished products segment accounted for the largest product type segment with a revenue of USD 2,055.4 million in 2017.

Some of the players operating in the pharmaceutical analytical testing outsourcing market are SGS SA, WuXi AppTec (WuXi STA), and Toxikon among others.

Browse Details @ https://www.marketresearchfuture.com/reports/pharmaceutical-analytical-testing-outsourcing-market-7188

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Comments

Post a Comment

Popular posts from this blog

Dry Age-Related Macular Degeneration Market Size, Share, Application Analysis, Regional Outlook, Growth Trends, Competitive Strategies

Image
  Dry Age-Related Macular Degeneration Market This degenerative eye disease is caused by the thinning of the macula and interferes with a clear vision in the elderly. The macula is part of the retina that facilitates clear vision; when this part of the eye deteriorates, it causes blurred or distorted vision. But this does not mean that the individual will lose his or her sight, only the central vision is affected by this degenerative disease, and the peripheral vision remains intact. Vision loss is slow and can be corrected using innovative ocular treatments. It has been estimated that the Dry Age-Related Macular Degeneration Market has seen a jump due to increased research in drugs, rising amount of COVID-19 cases among the old and age-restricted chronic diseases.   The dry age-related macular degeneration AMD market is expected to cross USD 15,351.07 million by 2027 at a CAGR of 8.20% during the forecast period   List of Key Companies Covered...
Read more

Cardiopulmonary Resuscitation Market: Innovations and Trends Shaping Life-Saving Techniques

  Introduction Cardiopulmonary Resuscitation (CPR) stands as a vital life-saving technique that has transformed emergency healthcare. As the cornerstone of effective response to cardiac arrest, the CPR market has been witnessing remarkable advancements driven by technology, research, and innovation. This article delves into the evolving landscape of the Cardiopulmonary Resuscitation Market, highlighting its trends, innovations, and impact on global healthcare. CPR: A Lifeline in Critical Moments Cardiopulmonary resuscitation, commonly referred to as CPR, is a crucial technique employed to sustain blood circulation and provide oxygen to the brain during cardiac arrest. It involves chest compressions and, in some cases, rescue breaths to maintain oxygen levels until professional medical assistance arrives. CPR significantly increases the chances of survival when performed promptly and correctly. Market Growth and Trends The CPR market has been experiencing steady growth due to incre...
Read more

Pain Management Devices Market Set To Exhibit Strong Growth, Valuable Research Factors and Industry Forecast to 2030

Image
  Pain Management Devices Market – Overview The Pain Management Devices Market can anticipate expansion at a rate of 7.12% from 2020 to 2030, believes MRFR (Market Research Future). Progress in technology and better research capabilities have led to the development of devices that can control pain with limited use of drugs. Focused Market reports connected to the healthcare sector among others lately have been made available by Market Research Future which publishes a report on this sector. The development of pain management devices has been useful to control pain in a wide range of ailments. The level of relief from pain that is experienced, is one of the major driving factors for the industry, as patients who use such devices are prone to chronic pain daily. Cancer patients and the geriatric population are among the major user segments for the pain management devices as medication alone may not be sufficient to provide pain relief in their situation. The industry is antici...
Read more